Clear all search history
Law & Crime
Disasters & Accidents
War & Conflict
Hospitality & Recreation
Rituxan articles over last 30 days
articles last 30 days
articles per day
Mentioned in this news
Fulda Free Press
On June 3, 2014 I went to the Avera Cancer Prairie Center and met Dr. Galal. They did blood work immediately. We discussed with Dr. Galal about my weight loss, nightly sweats and always tired. Dr....
Read more at Fulda Free Press
New Teva AstraZeneca Deals To Bolster Emerging Bi...
After this week, it looks like there will be a few big players advancing in the biosimilar market. For those concerned about what a Teva-Mylan acquisition deal would do to the generics industry,...
Read more at PharmaceuticalOnline
Biogen's Drop Looks Like Overreaction
Biogen reported disappointing second-quarter results and lowered its guidance for the full year, largely because of lower demand for Tecfidera in the United States and a weaker pricing environment in...
Read more at Morningstar
AstraZeneca chases biosimilar Avastin drug with J...
LONDON: AstraZeneca is dipping its toe in the biosimilars market, as a way to make future cancer drug cocktails more affordable, by linking with a Japanese group to develop a copy of Roche's...
Read more at Channel NewsAsia
Roche First-Half Earnings Drop 2% as Swiss Franc ...
... -- Roche Holding AG, the world’s biggest maker of cancer drugs, said first-half earnings fell 2 percent as the strength of the Swiss franc eroded sales. Earnings excluding some items,...
Read more at
+ 1 more articles
Roche Holding AG
Live updates: Cancer doctor who ordered unnecessa...
Live updates in comments section below. Excerpts from written victim statements in gallery above. DETROIT, MI -- After nearly two years of seething resentment over the suffering of lost loved ones,...
Read more at
+ -1 more articles
U.S. District Court
A Pharma Payment A Day Keeps Docs’ Finances Okay
Few days went by last year when New Hampshire nephrologist Ana Stankovic didn’t receive a payment from a drug company. All told, 29 different pharmaceutical companies paid her $594,363 in 2014,...
Read more at Long Island Press
Harvard Medical School
Latest from Twitter
Interceder is a topic search engine aggregating the latest news on any topic into a single window of information. This page has been automatically generated. To contact Interceder
Your privacy is important. Interceder does not collect and keep any personal information about visitors to the site. Interceder may use third-party advertising companies to serve ads. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements on this website, other websites, and other forms of media about goods and services of interest to you.